In a previous study, Bronden et al reported improvements in glycemia and LDL cholesterol in subjects with type 2 diabetes after a short (seven day) sevelamer course (16), although insulin sensitivity was not evaluated. The gene discussed is INS; the disease is type 2 diabetes mellitus.